Firdapse Tablet
Product Images NDC 69616-211

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Firdapse (NDC 69616-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Catalyst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fir0e 0000 01)

Chemical structure diagram of amifampridine phosphate, showing the pyridine ring with amino groups and the phosphate (H3PO4) molecule.*

FDA Label Image

Figure (Fir0e 0000 02)

Firdapse 10 mg oral tablets packaging label showing the product name, strength, and a tablet illustration. The label includes the nonproprietary name amifampridine phosphate and is labeled by Catalyst Pharmaceuticals, Inc.*

FDA Label Image

Figure (Fir0e 0000 03)

The image shows a plain white tablet bottle with a child-resistant cap. There are no visible markings or labels on the bottle to indicate the product name, strength, or manufacturer. It is consistent with typical packaging for oral tablets like those of Firdapse (amifampridine phosphate) 10 mg by Catalyst Pharmaceuticals, Inc.*

FDA Label Image

Figure (Fir0e 0000 04)

FDA Label Image

Figure (Fir0e 0000 05)

An illustration of a catheter tip syringe is shown in simple line drawing style. The syringe is angled diagonally and includes a plunger, barrel with measurement markings, and a tapered catheter tip for fluid administration.*

FDA Label Image

Figure (Fir0e 0000 06)

An illustration depicting a Firdapse tablet being placed into a prescription pill bottle. The bottle has a child-resistant cap shown removed beside it, indicating the packaging and handling of Firdapse (amifampridine phosphate) tablets 10 mg by Catalyst Pharmaceuticals, Inc.*

FDA Label Image

Figure (Fir0e 0000 07)

An instructional illustration demonstrating the addition of 10 mL of sterile water to a bottle for each tablet. The image includes a dropper syringe positioned above a bottle containing water, indicating the step for preparation or dilution.*

FDA Label Image

Figure (Fir0e 0000 08)

An instructional illustration showing a medication bottle with shaking motion lines and a partial dose indicator inside. Text instructs to shake the bottle well for 30 seconds, with a 5-minute timer symbol above the instructions.*

FDA Label Image

Figure (Fir0e 0000 09)

An instructional illustration showing a syringe with blue liquid drawn into its barrel, above a container partially filled with blue liquid. The syringe's plunger is labeled 'pull plunger to measure dose,' demonstrating how to draw medication from the container.*

FDA Label Image

Figure (Fir0e 0000 10)

An instructional illustration showing a side profile of a person using a syringe. The image includes text instructing to "push plunger to administer by mouth," indicating oral administration of a liquid medication with the syringe.*

FDA Label Image

Figure (Fir0e 0000 11)

An instructional diagram showing a syringe filled with a blue liquid. The diagram includes an arrow pointing upward and text instructing to 'pull plunger to measure dose,' indicating the step to draw the correct dose into the syringe.*

FDA Label Image

Figure (Fir0e 0000 12)

An instructional illustration showing a syringe filled with liquid and an attached feeding tube. The image includes text directing to inject medicine into the feeding tube, indicating medication administration via oral feeding tube.*

FDA Label Image

Figure (Fir0e 0000 13)

An instructional illustration showing a pull plunger being used to refill a syringe with sterile water from a container, indicating the plunger should be pulled up to refill.*

FDA Label Image

Figure (Fir0e 0000 14)

An instructional illustration showing a syringe with blue liquid inside. The image includes arrows indicating shaking motion and the text 'shake the syringe.' This diagram demonstrates how to properly shake the syringe before use.*

FDA Label Image

Image Description (Fir0e 0000 15)

Packaging label for Firdapse (amifampridine) Tablets, 10 mg per tablet, manufactured for Catalyst Pharmaceuticals, Inc. The label states the package contains 120 tablets total, provided in 12 child-resistant blister cards of 10 tablets each. It includes storage instructions, a barcode, and has NDC 69616-211-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.